The latest closing stock price for PTC Therapeutics as of January 21, 2025 is 45.25.
An investor who bought $1,000 worth of PTC Therapeutics stock at the IPO in 2013 would have $1,744 today, roughly 2 times their original investment - a 8.78% compound annual growth rate over 12 years.
The all-time high PTC Therapeutics stock closing price was 77.53 on March 17, 2015.
The PTC Therapeutics 52-week high stock price is 54.16, which is 19.7% above the current share price.
The PTC Therapeutics 52-week low stock price is 23.58, which is 47.9% below the current share price.
The average PTC Therapeutics stock price for the last 52 weeks is 35.14.
An investor who bought $1,000 worth of PTC Therapeutics stock at the IPO in 2013 would have $1,744 today, roughly 2 times their original investment - a 8.78% compound annual growth rate over 12 years.
The all-time high PTC Therapeutics stock closing price was 77.53 on March 17, 2015.
The PTC Therapeutics 52-week high stock price is 54.16, which is 19.7% above the current share price.
The PTC Therapeutics 52-week low stock price is 23.58, which is 47.9% below the current share price.
The average PTC Therapeutics stock price for the last 52 weeks is 35.14.